Beth Israel Hospital

Boston, Massachusetts 02215

0 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia, Platinum-resistant Ovarian Cancer, Prostate Cancer, Prostatic Neoplasms

Studies at this site

• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) — Completed
• An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy — Completed